Nicotine patches - Do they influence seizure number, stay durations or seizure rate during video EEG telemetry?

Epilepsy and Behavior

Volumn 23, Issue 3, 2012, Pages 389-391

  Parikh, Mihir S ^a   Haltiner, Alan M ^a   de Menezes, Marcio S ^a   Caylor, Lisa M ^a   Sepkuty, Jehuda P ^a   Simon, Ednea A ^a   Schoenfeld, Jenny L ^a   Doherty, Michael J ^a  

^a Swedish Epilepsy Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CHOLINERGIC RECEPTOR; CYCLIC AMP; DOPAMINE; MU OPIATE RECEPTOR; NICOTINE GUM; NICOTINE PATCH; NICOTINIC ACID; SEROTONIN;

BLOOD BRAIN BARRIER; CIGARETTE SMOKING; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE DURATION; DRUG EFFECT; ELECTROENCEPHALOGRAM; FRONTAL LOBE EPILEPSY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INSTITUTIONAL REVIEW; LETTER; PATIENT CARE; PATIENT MONITORING; PATIENT REFERRAL; PHYSICIAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; SEIZURE; SEIZURE THRESHOLD; SELF REPORT; TELEMETRY; TOBACCO DEPENDENCE;

ADOLESCENT; ADULT; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; SEIZURES; TELEMETRY; TOBACCO USE CESSATION PRODUCTS; VIDEO RECORDING; YOUNG ADULT;

EID: 84858282451     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2011.12.007     Document Type: Letter

References (13)

1. Chen Y., Wu L., Fang Y., et al. A novel mutation of the nicotinic acetylcholine receptor gene CHRNA4 in sporadic nocturnal frontal lobe epilepsy. Epilepsy Res 2009, 83:152-156.
2. Brodtkorb E., Picard F. Tobacco habits modulate autosomal dominant nocturnal frontal lobe epilepsy. Epilepsy Behav 2006, 9:515-520.
3. Willoughby J.O., Pope K.J., Eaton V. Nicotine as an antiepileptic agent in ADNFLE: an N-of-one study. Epilepsia 2003, 44:1238-1240.
4. Schoenfeld J., Sotero De Menezes M. Nicotine patch for the treatment of intractable ADNFLE in a non-smoking pediatric patient Abst. 2.238 AES 2010 available online at:, accessed 9/24/2011. http://www.aesnet.org/go/publications/aes-abstracts/abstract-search/mode/display/st/sotero/sy/2010/sb/All/id/12832.
5. Le Houezec J. Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review. Int J Tuberc Lung Dis 2003, 7:811-819.
6. Beghi E., Cornaggia C. Morbidity and accidents in patients with epilepsy: results of a European cohort study. Epilepsia 2002, 43:1076-1083. for RESt-1 Group.
7. Dobesberger J., Walser G., Unterberger I., et al. Video-EEG monitoring: safety and adverse events in 507 consecutive patients. Epilepsia 2011, 52:443-452.
8. Lie O., Kim W., Miller JW J., Oakley J.C. A probability estimate for the time to first diagnostic event during long-term video-EEG monitoring Abst. 1.072, AES 2010 Accessed online at:, Accessed 9/24/2011. http://www.aesnet.org/go/publications/aes-abstracts/abstract-search/mode/display/st/oakley/sy/2010/sb/All/id/12272.
9. Benbadis S.R., O'Neill E., Tatum W.O., Heriaud L. Outcome of prolonged video-EEG monitoring at a typical referral epilepsy center. Epilepsia 2004, 45:1150-1153.
10. Ghougassian D.F., d'Souza W., Cook M.J., Brien T.J. Evaluating the utility of inpatient video-EEG monitoring. Epilepsia 2004, 45:928-932.
11. Stitzel J.A. Naturally occurring genetic variability in the nicotinic acetylcholine receptor alpha4 and alpha7 subunit genes and phenotypic diversity in humans and mice. Front Biosci 2008, 1:477-491.
12. Xiu X., Puskar N.L., Shanata J.A., Lester H.A., Dougherty D.A. Nicotine binding to brain receptors requires a strong cation-π interaction. Nature 2009, 458:534-537.
13. David S.P., Johnstone E.C., Churchman M., Aveyard P., Murphy M.F., Munafo M.R. Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials. Nicotine Tob Res 2011, 13:157-167.